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Background: Genetic variants near/within the ALDH2 gene encoding the mitochondrial aldehyde dehydrogenase 2
have been associated with blood pressure and hypertension in several case–control association studies in East
Asian populations.
Methods: Three common tag single nucleotide polymorphisms (tagSNP) in the ALDH2 gene were genotyped in
1,134 subjects of Chinese origin from the Stanford Asia-Pacific Program for Hypertension and Insulin Resistance
(SAPPHIRe) family cohort. We examined whether the ALDH2 SNP genotypes predicted the development of
hypertension in the prospective SAPPHIRe cohort.
Results: Over an average follow-up period of 5.7 years, carriers homozygous for the rs2238152 T allele in the ALDH2
gene were more likely to progress to hypertension than were non-carriers (hazard ratio [HR], 2.88, 95% confidence
interval [CI], 1.06-7.84, P= 0.03), corresponding to a population attributable risk of ~7.1%. The risk associated with the
rs2238152 T allele were strongest in heavy/moderate alcohol drinkers and was reduced in non-drinkers, indicating an
interaction between ALDH2 genetic variants and alcohol intake on the risk of hypertension (P for interaction = 0.04).
The risk allele was associated with significantly lower ALDH2 gene expression levels in human adipose tissue.
Conclusion: ALDH2 genetic variants were associated with progression to hypertension in a prospective Chinese
cohort. The association was modified by alcohol consumption.
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The ALDH2 gene encodes the mitochondrial aldehyde
dehydrogenase 2, a critical enzyme involved in alcohol
metabolism. After alcohol ingestion, ethanol is first
oxidized to acetaldehyde by alcohol dehydrogenase and
subsequently converted to acetic acid by ALDH2 [1].
A substantial proportion of the East Asian population* Correspondence: leeming@ntu.edu.tw
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reproduction in any medium, provided the orcarries the rs671 A allele of the ALDH2 gene causing the
E487K mutation (glutamate at codon 487 replaced by ly-
sine) [2,3]. A marked elevation of circulating acetalde-
hyde after alcohol ingestion is observed in carriers with
mutant alleles [4]. Acetaldehyde is a toxic metabolite of
ethanol that causes the classical symptoms of headache,
nausea, palpitation and facial flushing [2,4]. Elevation of
acetaldehyde has also been shown to alter blood pres-
sure in experimental animal models [5-7]. In addition to
alcohol-metabolizing activity, recent research has identi-
fied ALDH2 as an enzyme responsible for the bioactiva-
tion of nitroglycerin in animals and human. ALDH2
catalyzes the conversion of nitroglycerin to 1,2-glycerylLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 ALDH2 SNP information
Name Minor/Major allele Gene Region HW P %Geno MAF
rs2238152 T/G Intron 0.61 99.03 0.233
rs671 A/G Exon Glu504Lys 0.23 99.21 0.261
rs2158029 G/A Intron 0.68 99.38 0.343
HW P, Hardy –Weinberg P value; MAF, minor allele frequency; % Geno,
genotyping call rate.
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smooth muscle relaxation [8,9]. These data suggests that
ALDH2 is important for blood pressure regulation.
Consistent with these experimental studies, several
cross-sectional or case–control association studies have
reported a significant association between ALDH2 SNPs
and blood pressure or hypertension [10-19]. In this
study, we aimed to examine whether common ALDH2
genetic polymorphism predict development of hyperten-
sion in a prospective Chinese family cohort. We adapted
a gene-based approach by systemically genotyping com-
mon tag SNPs capturing the ALDH2 gene. We also
explored potential gene-environmental interaction be-
tween ALDH2 genotypes and various environmental risk
factors.
Methods
The SAPPHIRe study cohort
The Stanford Asia-Pacific Program for Hypertension and
Insulin Resistance (SAPPHIRe) was a collaborative study
that was part of the Family Blood Pressure Program of
the National Heart, Lung and Blood Institute of the Na-
tional Institutes of Health and was designed to investi-
gate the genetic determinants of hypertension and
insulin resistance in the Chinese and Japanese indivi-
duals. The study collected sibling pairs who were either
concordant or discordant for high blood pressure.
Detailed descriptions of the study cohort were published
in our previous work [20]. Hypertension was defined as
systolic blood pressure ≧140 mmHg or diastolic blood
pressure ≧90 mmHg or use of medications for high
blood pressure. Individuals with pre-existing chronic ill-
ness such as diabetes, cancer, or diseases of the heart,
liver, or kidney were excluded. The SAPPHIRe cohort
study consisted of 6 field centers at baseline, including 4
field centers in Taiwan, one in Hawaii and one in Stan-
ford University (San Francisco Bay area). A total of 1,143
subjects of Han Chinese descent from 392 families were
enrolled at baseline. The follow-up study was conducted
in the 4 Taiwan field centers and 753 individuals from
276 families were followed-up through the entire study.
Other reasons of lost to follow-up included death
(0.21%), lost of contact (5.7%), and rejection (16.56%).
The Institutional Review Board of Tri-Service General
Hospital in Taiwan, the National Taiwan University Hos-
pital Research Ethics Committee, the Institutional Re-
view Board of Taipei Veterans General Hospital, and the
Institutional Review Board of Taichung Veterans General
Hospital approved this study. Written informed consent
was obtained from each participant.
Clinical measurement
Blood pressure was measured using a mercury sphygmo-
manometer in 3 separate intervals at rest. Standardizedinterview-administered questionnaires were used to ob-
tain information on demographic and lifestyle character-
istics as previously described [21]. In brief, each
participant was asked about smoking status and was
categorized as non-smokers, ex-smokers or current
smokers. Those who no longer smoked, but had
smoked before were categorized as ex-smokers. The
monthly alcohol consumption, grams of ethanol per
day, was calculated based on the amount of usual inges-
tion of beer (5% ethanol), wine (12.5% ethanol), sake
(16% ethanol) and liquor (40% ethanol) for each subject
by a face-to-face interview. Light, modest, and heavy
drinking was defined as average daily ethanol consump-
tion 0–5 g, 5–10 g, and more than 10 g respectively
[21]. Physical activity was assessed by recording the
number of hours per day spent at each of five levels of
activity [21].
Selection of tag SNPs and genotyping
To identify common tag SNPs, we selected SNPs from
the HapMap CHB (Chinese Beijing) database (HapMap
Genome Browser release #24) (http://www.hapmap.org)
using the Tagger program implemented in Haploview
version 4 (http://www.broad.mit.edu/mpg/haploview/)
with a minor allele frequency threshold of 0.1 and r2 of
0.8 [22,23]. Three tag SNPs that captured 100% of SNPs
with minor allele frequencies more than 10% with mean
maximal r2 = 0.962 were selected. The genotyping call
rate was listed in Table 1. The concordance rate of this
system based on 160 genotyping duplication was 99.38%.
Subjects for adipose tissue sampling
We additionally recruited 48 morbidly obese adults
undergoing weight-loss surgery in Min-Sheng Hospital in
Taiwan. Abdominal visceral adipose tissue was biopsied
in a fasting state during surgery. Informed consent was
obtained from each patient. The study was approved by
the Institutional Review Board of Min-Sheng Hospital.
Adipose tissue RNA extraction and reverse transcription
(RT)
Adipose tissue was placed in liquid nitrogen immediately
after resection and stored at −80°C until processed.
Total RNA was extracted using REzol (Promega, Madi-
son, WI) according to the manufacturer's instructions.





Age (year) 48.39 ± 9.05 29.10 ± 8.24
Male sex (%) 46.83 14.89
BMI (kg/m2) 24.98 ± 3.44 40.93 ± 5.15
Waist circumference (cm) 83.59 ± 10.43 116.8 ± 10.79
Fasting glucose (mg/dl) 88.57 ± 10.61 105.3 ± 48.9
Fasting insulin 7.43 ± 5.58 21.6 ± 15.3
SBP (mmHg) 127.7 ± 24.15 124.6 ± 11.9
DBP (mmHg) 76.53 ± 13.38 76.3 ± 9.46
Triglycerides (mg/dl) 121.8 ± 76.25 214.8 ± 342.5
Total cholesterol (mg/dl) 185.9 ± 39.35 199.0 ± 31.1
HDL-cholesterol (mg/dl) 44.77 ± 12.23 43.61 ± 12.07
LDL-cholesterol (mg/dl) 117.59 ± 37.87 132.8 ± 33.97
Data are presented as mean ± S.D. BMI, body mass index; SBP, systolic blood
pressure; DBP, diastolic blood pressure.
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(Promega, Madison, WI) with 1 μg of total RNA and
0.5 μg random hexamers in a final volume of 25 μl con-
taining 200 U of Maloney murine leukemia virus reverse
transcriptase, 20 nM dNTP, and 25 U of rRNasin for 1 h
at 37°C. The reaction mixture was diluted to 100 μl with
double-distilled water prior to PCR amplification.
Quantification of mRNA expression levels by real-time
PCR
A 5-μl sample of diluted cDNA was added to a mixture
comprised of 10-μl 2x SYBR Master Mix Buffer to a final
volume of 20 μL (Applied Biosystems, Foster City, CA).
The pre-developed primers for ALDH2 were PPH17047A-
200 (QUIAGEN, Hilden, Germany). The primer sequence
for PPIA (cyclophilin A) were:5' AGG TCC CAA AGA
CAG CAG AAA AT 3' (forward) and 5' GTG AAA GCA
GGA ACC CTT ATA ACC 3'(reverse). Thermocycling
was done by 10 min at 95°C followed by 40 cycles of
30 sec at 95°C, 1 min at 60°C and 1 min at 72°C. Real-
time quantitative PCR was analyzed by the ABI PRISM
7000 Sequence Detection System (Applied Biosystems,
Foster City, CA). The fluorescent signal from each PCR
reaction was collected as a peak-normalized value plotted
versus the cycle number. Reactions were characterized by
comparing the threshold cycle (Ct) values. Relative gene
expression in relation to cyclophilin A RNA was calcu-
lated using the formula: ΔCt= (Ct of cyclophilin A) – (Ct
of ALDH2).
Statistical analysis
All data are expressed as mean values ± standard
deviations (SD) unless otherwise specified. Tests for
Hardy-Weinberg equilibrium were performed before
marker-trait analysis. Pairwise LD measures D' and r2
were estimated to assess linkage disequilibrium (LD) be-
tween the SNPs in the ALDH2 gene. The structure of the
haplotype block was evaluated using the solid spine LD
method implemented in the Haploview program [23].
Cox proportional hazard models were used to assess
associations between the time to each progression event
and the SNPs in the ALDH2 gene. Hazard ratio (HR) for
a genotype versus the reference genotype was estimated
and 95% confidence intervals (CI) for these hazard ratios
were also computed. We accounted for the correlations
resulting from the sibship data in the modeling. To
analyze the association of ALDH2 genetic variants with
quantitative traits, tests for population stratification and
total association were performed using the quantitative
transmission disequilibrium test (QTDT) program
(http://www.sph.umich.edu/csg/abecasis/QTDT), which
is based on a variance-components framework [24]. A test
for total association was performed if there was no signifi-
cant population stratification. The parameter estimatesassociated with each additional minor allele were esti-
mated with generalized estimating equation. P-values
were adjusted for age, sex, smoking and physical activity,
and alcohol consumption. The study-wide significance
threshold required for type 1 error less than 5% is esti-
mated using the method proposed by Nyholt et al. which
takes into account the LD between markers [25]. The
population attributable fraction was calculated as follows:
1-{1[p2 HRhomo+ 2p(1-p)HRhetero + (1-p)2]}, where p is
the risk-allele frequency, HRhomo is the hazard ratio for
homozygotes, and HRhetero is the hazard ratio for hetero-
zygotes. The association between the ALDH2 genotype
and ALDH2 gene expression in adipose tissue was ana-
lyzed using non-parametric trend test implemented in
STATA 9.0 (StataCorp LP, College Station, Texas).Results
Characteristics of study subjects, allele frequencies, and
LD structure
The basic clinical characteristics of participants at base-
line are shown in Table 2. The nucleic acid composition,
Hardy-Weinberg equilibrium test, genotyping call rate,
and minor allele frequencies of selected SNPs are sum-
marized in Table 1. The LD structure between SNPs is
shown in Figure 1. All SNPs were within the same LD
block. The allele frequencies of SNPs were similar to
those in the HapMap CHB database [22].SNP association with incidence of hypertension and
changes of blood pressure during follow-up
Over an average follow-up period of 5.7 year, partici-
pants homozygous for the rs2238152 T allele (minor
Figure 1 LD between ALDH2 SNPs in the SAPPHIRe cohort.
Pairwise LD coefficients D' × 100 are shown in each cell (D'
values of 1.0 are not shown). The standard color scheme was
applied for LD color display (LOD score ≥2 and D' =1 in bright red;
LOD score ≥2 and D' <1 in blue; LOD score <2 and D' =1 in pink;
LOD score <2 and D' <1 in white).
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hypertension to hypertension (HR= 2.88; 95% CI: 1.06-
7.84; P= 0.03) than did non-carriers (Table 3). The
genetic model was best fit with a recessive genetic
mode and the corresponding population attributable
risk fraction is ~7.1%. Participants homozygous for the
mutant rs671 A allele had only a trend of increased
hypertension incidence (HR= 2.13; 95% CI: 0.77-5.89;Table 3 Association of ALDH2 genotypes with progression to
Incident cases/ 100 person-year (number of inciden
AA Aa aa
rs2238152 3.84(27) 3.12(11) 5.47(4)
rs671 4.08(25) 3.02(13) 5.00(4)
rs2158029 4.11(21) 2.69(13) 5.72(8)
A: major allele; a: minor allele.P= 0.15) compared to non-carriers. However, rs2238152
T allele was not significantly associated with changes of
systolic/diastolic blood pressure (SBP/DBP) during
follow-up. In contrast, the mutant rs671 A allele was
significantly associated with increases of SBP
(0.865 mmHg increase per year, P= 0.0071) and DBP
(0.537 mmHg increase per year, P= 0.0026) during
follow-up (Table 4).
Interaction between environmental factors and SNPs on
hypertension risk
We next examined whether there was interaction be-
tween the ALDH2 SNP and environmental factors on
the risk of hypertension. The rs2238152 T allele was
associated with higher incidence of hypertension in par-
ticipants with moderate or heavy alcohol intake (inci-
dence of hypertension: 4.32, 5.36, and 17.0 cases/person
year for rs2238152 TT, TG, and GG genotype, respect-
ively) (Figure 2). However, the genetic effect disappeared
in participant who did not drink (incidence of hyperten-
sion: 3.94, 2.45, and 1.8 cases/person year for rs2238152
TT, TG, and GG genotype, respectively), indicating an
interaction between SNPs and alcohol intake on the risk
of hypertension (P for interaction = 0.04) (Figure 2). We
did not detect significant interaction between ALDH2
SNPs and other environmental factors including age,
sex, smoking or physical activity on hypertension risk
(data not shown).
SNP association with ALDH2 mRNA in human adipose
tissue
We further explored possible mechanism by which SNP
rs2238152 affect clinical phenotypes. We measured
ALDH2 mRNA levels in human abdominal adipose tis-
sue sampled from 48 adults. The rs2238152 T allele was
associated with a significantly lower ALDH2 gene ex-
pression level (P= 0.03) (Figure 3). Other SNPs were not
associated with ALDH2 gene expression level (Add-
itional file 1: Figure S1).
Discussion
In this study, we demonstrated that a common ALDH2
genetic polymorphism was associated with progression
to hypertension in a prospective Chinese cohort. The as-
sociation was strongest in participants with heavy/hypertensions in SAPPHIRe cohort
t case) Hazard ratio
for Aa vs. AA
(95%CI)
P Hazard ratio
for aa vs. AA
(95%CI)
P
0.93 (0.46-1.87) 0.83 2.88 (1.06-7.84) 0.03
1.08 (0.51-2.29) 0.84 2.13 (0.77-5.89) 0.15
0.83 (0.4-1.7) 0.60 1.94 (0.79-4.77) 0.15
Table 4 Association of ALDH2 genotypes with changes of
systolic/diastolic blood pressure in SAPPHIRe cohort
rs2238152 rs671 rs2158029
Estimate P* Estimate P* Estimate P*
Δ systolic blood
pressure
0.0564 0.86 0.865 0.0071 0.269 0.38
Δ diastolic blood
pressure
0.0316 0.87 0.537 0.0026 0.0241 0.89
Estimate: the changes in systolic/diastolic blood pressure associated with each
additonal risk allele during follow-up.
* adjusted for age, sex, alcohol intake, smoking, drugs, and physical activity.
Corrections of blood pressure for antihypertensive drugs (10/5 mmHg
reduction per drug) was made.
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who did not drink, indicating an interaction between
ALDH2 genetic variation and alcohol consumption on
hypertension risk. To our knowledge, this is the first
prospective cohort study demonstrating that ALDH2
genetic polymorphism predicts development of hyper-
tension in East Asian population.
Several cross-sectional studies and case–control asso-
ciation studies have consistently reported significant as-
sociation between ALDH2 genetic polymorphisms and
blood pressure and hypertension in East Asian popula-
tion [10-16]. A recent meta-analysis including 7,658 sub-
jects determined that the rs671 A allele was associated
with a significantly lower odds ratio of hypertension and
lower blood pressure. In our study, rs671 was associated
with a significant increase of blood pressure and a trend
of increased hypertension risk during follow-up. Another
adjacent SNP rs2238152, which was in complete LD with
rs671 (D' = 1), was associated with increased risk for inci-
dent hypertension but was not associated with significant
changes in blood pressure. The discrepancy between as-
sociation with hypertension risk and changes of blood
pressure may be partly attributed to the confounding ofFigure 2 ALDH2 genotype interaction with alcohol intake on progressantihypertensive medication. In a recent large GWAS
meta-analysis for hypertension in east Asian, Kato, et al.
reported a strong association signal ~ 0.5 Mb down-
stream the ALDH2 gene (P= 5.9 × 10-13)[18]. Daniel,
et al. also reported strong association signal for diastolic
blood pressure in the SH2B3 gene (P= 1.6 × 10-14) in a
GWAS for hypertension in Caucasian. The SH2B3 gene
is located in a large LD block spanning the ALDH2 gene
[19]. It is possible that the true causal variant is in LD
with rs2238152 or rs671. Further fine mapping is needed
to clarify the true causal variant.
We further explored the potential gene-environmental
interaction between ALDH2 variants and environmental
factors on hypertension risk. Alcohol intake modified
the genetic effect of ALDH2 variant on hypertension
risk. The mechanism underlying this interaction is cur-
rently unknown. Based on this observation, we propose
that alcohol consumption level should be taken into
account when ALDH2 genetic information is used to
predict further hypertension risk. We further demon-
strated that the risk allele was associated with lower
ALDH2 gene expression in human adipose tissue. This
suggested that the risk variant may influence the clinical
phenotype though altered ALDH2 gene expression.
Our study has 3 unique strengths. First, population
stratification is still a common concern of case–control
association studies, which may lead to false positive
results. The family-based design of SAPPHIRe essentially
eliminates all potential population stratification. Second,
case–control studies are often confounded by recall bias
or ascertainment bias. This study is a prospective co-
hort study with comprehensive records of baseline
exposures and thus is free of such bias. Third, the en-
vironmental exposures were comprehensively recorded
in the SAPPHIRe study, making a thorough exploration
for gene-environment interaction possible.ion to hypertension in the SAPPHIRe cohort.
Figure 3 ALDH2 gene expression level in abdominal adipose
tissue according to rs2238152 genotype. Relative gene
expression in relation to cyclophilin A RNA was calculated using the
formula: ΔCt = (Ct of cyclophilin A) – (Ct of ALDH2).
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is relatively small with limited incident case so that a
chance finding is not unlikely. The power of this study
to detect variants with small effect is also limited. Given
the hypertension prevalence of 25%[26] among the
Chinese and a minor allele frequency of 0.25, the power
to detect allelic odds ratios of 1.2, 1.5, and 2.0 for hyper-
tension was 16.1%, 56.2%, and 95.1% respectively with
type I error rate of 0.05. Second, the association between
the rs2238152 genotype and progression to hypertension
(P= 0.03) did not pass the significance threshold
adjusted for multiple testing. For a type 1 error less than
5%, the study-wide significance threshold is estimated to
be 0.02 after correction for the LD between each SNP
[25]. However, previous cross-sectional or case–control
studies had demonstrated significant association be-
tween ALDH2 variants and hypertension. From a Bayes-
ian point of view, the prior probability is already high
and therefore stringent correction for multiple testing
may not be necessary.Conclusion
In summary, we demonstrated that ALDH2 genetic
polymorphism predicted development of hypertension
in a prospective cohort. Alcohol intake significantly
modified the conferred risk. These data strengthen
current evidence linking ALDH2 genetic variants with
hypertension.Additional file
Additional file 1: Figure S1. ALDH2 gene expression level in abdominal
fat tissue according to rs671 (A) and rs2158029 (B) genotypes. Relative
gene expression in relation to cyclophilin A RNA was calculated using the
formula: ΔCt = (Ct of cyclophilin A) – (Ct of ALDH2).
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